Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• Artificial intelligence and colonoscopy experience: lessons from two randomised trials1 passage
• Asian Pacific Association of Gastroenterology task force recommendations on surveillance for <i>Helicobacter pylori</i> associated gastric premalignant conditions25 passages
• Assessment of Crohn's disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review1 passage
• Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis1 passage
• BSG/ACPGBI guidance on the management of colorectal polyps in patients with limited life expectancy1 passage
• British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults25 passages
• British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma1 passage
• British Society of Gastroenterology guidelines on the management of functional dyspepsia1 passage
• British Society of Gastroenterology guidelines on the management of irritable bowel syndrome1 passage
• Choice of colon capsule or colonoscopy versus default colonoscopy in FIT positive patients in the Danish screening programme: a parallel group randomised controlled trial1 passage
• Combination of carvedilol with variceal band ligation in prevention of first variceal bleed in Child-Turcotte-Pugh B and C cirrhosis with high-risk oesophageal varices: the 'CAVARLY TRIAL'1 passage
• Consensus definition of sludge and microlithiasis as a possible cause of pancreatitis1 passage
• Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis1 passage
• Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study1 passage
• Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis1 passage
• Endoscopic or surgical gastroenterostomy for malignant gastric outlet obstruction: a randomised trial1 passage
• Endoscopic variceal ligation versus propranolol for the primary prevention of oesophageal variceal bleeding in patients with hepatocellular carcinoma: an open-label, two-centre, randomised controlled trial1 passage
• Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update1 passage
• Endosonography-guided gallbladder drainage versus percutaneous cholecystostomy in very high-risk surgical patients with acute cholecystitis: an international randomised multicentre controlled superiority trial (DRAC 1)1 passage
• First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: a systematic review and network meta-analysis1 passage
• Gastric microbes associated with gastric inflammation, atrophy and intestinal metaplasia 1 year after Helicobacter pylori eradication1 passage
• Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis1 passage
• Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG)1 passage
• Guidelines on the management of ascites in cirrhosis25 passages
• Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis1 passage
• High versus gradually increasing energy nutrition in the early phase of acute pancreatitis (GOULASH): a multicentre double-blind randomised clinical trial1 passage
• Improved adenoma detection with Endocuff Vision: the ADENOMA randomised controlled trial1 passage
• International consensus to standardise histopathological scoring for small bowel strictures in Crohn's disease1 passage
• Lifestyle factors, genetic susceptibility and risk of incident diverticulitis: an integrated analysis of four prospective cohort studies and electronic health records-linked biobank1 passage
• Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations1 passage
• Number of reflux episodes on pH-impedance monitoring associates with improved symptom outcome and treatment satisfaction in gastro-oesophageal reflux disease (GERD) patients with regurgitation1 passage
• Parecoxib sequential with imrecoxib for occurrence and remission of severe acute pancreatitis: a multicentre, double-blind, randomised, placebo-controlled trial1 passage
• Preoperative administration of the 5-HT4 receptor agonist prucalopride reduces intestinal inflammation and shortens postoperative ileus via cholinergic enteric neurons1 passage
• Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis1 passage
• Prevention of rebleeding after primary haemostasis using haemostatic powder in non-variceal upper gastrointestinal bleeding: a multicentre randomised controlled trial1 passage
• Quality standards in upper gastrointestinal endoscopy: a position statement of the British Society of Gastroenterology (BSG) and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS)1 passage
• Real-time automatic detection system increases colonoscopic polyp and adenoma detection rates: a prospective randomised controlled study1 passage
• The management of adult patients with severe chronic small intestinal dysmotility1 passage
• Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension1 passage
• Updated guideline on the management of common bile duct stones (CBDS)1 passage
• Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study1 passage